Illumina Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $4.5B+2.8% YoYTTM through 28 Jun 2026
Net Income $825MTTM through 28 Jun 2026
Free Cash Flow $931MTTM through 28 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 66.1% |
| EBITDA Margin | 25.7% |
| Operating Margin | 19.2% |
| Net Margin | 18.4% |
Returns
29.1%ROE
12.4%ROA
Balance Sheet Health
Current Ratio1.80x
Cash & Equivalents$1B
Quality Metrics
Altman Z-Score7.21
Piotroski F-Score8 / 9
FCF Margin20.7%
Rule of 4023.6
Earnings-Beat Rate100.0%
Multi-Year Trend
RevenueFY2025: $4.3B
Diluted EPS$5.36TTMFY2025: $5.45
Dividend
No dividend
Capital Allocation
R&D Spend$960M
Capex Intensity3.6%
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.